NCT07467993: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- State
- Under way
- Phase
- Phase 2
- People
- 142 planned
- Started
- 16 Mar 2026
- Primary completion
- 29 Jul 2027
- Arms
- GXV813
- Results
- None posted
- 12 Mar 2026: Trial registered
- 16 Mar 2026: Trial started